Analytical rigor was ensured through LC-MS/MS with isotopically labeled standards, enabling precise quantification of TMA and TMAO across biofluids ( in vitro assays with purified TMA lyase (CutC/D) to clarify inhibition kinetics
Here are a handful of news and resources on the topic: In the news: Eli Lilly announces results from clinical trial of new triple agonist and partners with South Koreas Hanmi Pharma for a clinical-stage GLP-2 agonist
R.KobarfardF.NoubaraniM.HeidariH
Affiliation: Department of Neurology, Shandong University Qilu Hospital, Jinan 250012, Shandong, China ORCID: Affiliation: Department of Neurology, Shandong University Qilu Hospital, Jinan 250012, Shandong, China Affiliation: Department of Neurology, Shandong University Qilu Hospital, Jinan 250012, Shandong, China Affiliation: Department of Neurology, Shandong University Qilu Hospital, Jinan 250012, Shandong, China Email: [email protected] ORCID: Explor Neuroprot Ther